Bioprocess Considerations for Large Scale Transfection

BPI Contributor

September 16, 2022

20 Min View
Bioprocess Considerations for Large Scale Transfection

Date: Sep 16, 2022

Duration: 20 Min

This webcast features: Geddy Hamblen, Field Applications Scientist, Mirus Bio.

As demand for viral vectors has grown in recent years, larger production scales are increasingly common. As processes scale, transient transfection must also scale to match. The VirusGEN® family of transfection products, developed by Mirus Bio, has been used successfully at scale in clinical manufacturing and brings unique advantages leading to higher titers and a more robust manufacturing process.

In this webinar we will discuss:

  • Challenges and solutions for transfection at manufacturing scale, including the transfection complex formation step.

  • The advantages of VirusGEN® in optimizing a transfection workflow.

  • How VirusGEN® GMP AAV and LV products enable higher titers and more robust manufacturing processes.

Just fill out the form below to view the recorded webcast now.

You May Also Like